LNZA LanzaTech Global, Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 1843724 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY46.8%
TTM net income YoY88.9%
TTM EPS YoY99.0%
Revenue 3-yr CAGR2.9%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-51.2%
Net margin-14.4%
FCF margin-51.7%
EBITDA margin-44.0%
Returns
ROE-20.7%
ROA-7.0%
ROIC (approx.)-184.8%
Asset turnover0.49x
Leverage & solvency
Liabilities / assets39.0%
Debt / equity0.00x
Current ratio2.72x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.45x
Accruals ratio17.1%
Payout ratio—
Capex / revenue2.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $9.51M | $9.01M | $12.02M | $28.00M | $9.28M | $9.08M | $9.48M | $12.03M |
| R&D expense | $4.83M | $1.96M | $4.01M | $11.50M | $10.26M | $14.94M | $16.49M | $16.46M |
| SG&A expense | $5.93M | $8.75M | $8.59M | $5.45M | $6.74M | $19.11M | $15.75M | $15.74M |
| Operating income | -$10.09M | -$9.87M | -$9.81M | -$205,000 | -$15.66M | -$32.24M | -$31.05M | -$27.02M |
| Pretax income | — | — | — | — | — | — | -$12.70M | -$20.69M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$177.97M | $184.31M | -$14.68M | -$84,000 | $2.86M | -$32.50M | -$19.23M | -$26.99M |
| EBITDA | -$9.16M | -$8.91M | -$8.87M | $1.16M | -$14.63M | -$31.19M | -$30.27M | -$25.74M |
| EPS (basic) | -13.60 | 15.81 | -1.77 | — | 1.14 | -14.90 | -9.79 | — |
| EPS (diluted) | -13.60 | 15.81 | -1.77 | — | 0.99 | -14.90 | -9.79 | — |
| Weighted avg. shares (diluted) | 13.09M | 11.66M | 8.27M | — | 2.66M | 2.18M | 1.97M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $32.31M | $44.98M | $19.86M | $13.16M | $23.50M | $39.65M | $16.03M | $45.74M |
| Inventory | — | — | — | $684,000 | — | — | — | $2.16M |
| Current assets | $55.66M | $69.24M | $47.96M | $39.69M | $50.63M | $66.15M | $57.67M | $99.33M |
| PP&E, net | $15.21M | $15.86M | $16.15M | $17.13M | $18.29M | $19.21M | $20.23M | $22.33M |
| Total assets | $141.72M | $322.69M | $105.21M | $100.21M | $99.29M | $116.30M | $125.83M | $174.68M |
| Current liabilities | $20.43M | $27.91M | $24.41M | $27.72M | $24.84M | $55.82M | $26.52M | $30.45M |
| Total liabilities | $55.30M | $62.06M | $57.15M | $90.93M | $91.10M | $128.31M | $127.01M | $161.24M |
| Shareholders' equity | $86.43M | $260.64M | $48.06M | -$3.89M | -$4.98M | -$25.18M | -$1.17M | $13.45M |
| Shares outstanding | 13.09M | 13.09M | 10.09M | 2.32M | 2.32M | 232.00M | 197.90M | 1.95M |
| Cash flow statement | ||||||||
| Operating cash flow | -$12.22M | -$1.39M | -$9.27M | -$6.16M | -$15.88M | -$21.71M | -$21.10M | -$19.68M |
| Capital expenditure | $267,000 | $676,000 | $55,000 | $211,000 | $168,000 | $166,000 | $713,000 | $1.75M |
| Free cash flow | -$12.49M | -$2.06M | -$9.32M | -$6.37M | -$16.05M | -$21.88M | -$21.81M | -$21.43M |
| Investing cash flow | -$267,000 | -$1.72M | -$2.01M | -$211,000 | -$168,000 | $7.24M | $4.29M | $14.22M |
| Financing cash flow | $0 | $28.14M | $18.00M | $0 | $0 | $38.12M | -$12.50M | -$10.01M |
| Depreciation & amortization | $926,000 | $962,000 | $939,000 | $1.37M | $1.02M | $1.05M | $781,000 | $1.28M |
| Stock-based compensation | $478,000 | $739,000 | $1.33M | $1.29M | $1.36M | $2.28M | $2.28M | $3.47M |
Free plan shows the latest 8 periods; Pro shows all 21 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.